Product References
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1- stem cell-like T cells over PD-1+ T cells curbing tumor progression.
Frontiers in immunology
Del Rio ML,de Juan CY,Roncador G,Caleiras E,Álvarez-Esteban R,Pérez-Simón JA,Rodriguez-Barbosa JI
13-1371-82 was used in Flow cytometry/Cell sorting to highlight the role of co-inhibitory signals delivered by Herpes Virus Entry Mediator (HVEM, TNFRSF14) upon engagement of BTLA on T cells and NK cells, placing HVEM/BTLA interaction in the spotlight as a novel immune checkpoint for the reinforcement of the anti-tumor responses in malignancies of hematopoietic origin.
Thu Aug 10 00:00:00 UTC 2023
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells.
Cellular and molecular life sciences : CMLS
Meléndez AV,Velasco Cárdenas RM,Lagies S,Strietz J,Siukstaite L,Thomas OS,Tomisch J,Weber W,Kammerer B,Römer W,Minguet S
Published figure using CD137 (4-1BB) monoclonal antibody (Product # 13-1371-82) in Flow Cytometry
Mon Sep 12 00:00:00 UTC 2022
STARTRAC analyses of scRNAseq data from tumor models reveal T cell dynamics and therapeutic targets.
The Journal of experimental medicine
Bhatt D,Kang B,Sawant D,Zheng L,Perez K,Huang Z,Sekirov L,Wolak D,Huang JY,Liu X,DeVoss J,Manzanillo PS,Pierce N,Zhang Z,Symons A,Ouyang W
Published figure using CD137 (4-1BB) monoclonal antibody (Product # 13-1371-82) in Flow Cytometry
Mon Jun 07 00:00:00 UTC 2021
PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacy.
Oncoimmunology
Zahm CD,Moseman JE,Delmastro LE,G Mcneel D
Published figure using CD137 (4-1BB) monoclonal antibody (Product # 13-1371-82) in Flow Cytometry
Wed Apr 21 00:00:00 UTC 2021
Fas mutation reduces obesity by increasing IL-4 and IL-10 expression and promoting white adipose tissue browning.
Scientific reports
Choi EW,Lee M,Song JW,Kim K,Lee J,Yang J,Lee SH,Kim IY,Choi JH,Seong JK
Published figure using CD137 (4-1BB) monoclonal antibody (Product # 13-1371-82) in Flow Cytometry
Mon Jul 20 00:00:00 UTC 2020
Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer.
Cell reports
Choi H,Deng J,Li S,Silk T,Dong L,Brea EJ,Houghton S,Redmond D,Zhong H,Boiarsky J,Akbay EA,Smith PD,Merghoub T,Wong KK,Wolchok JD
Published figure using CD137 (4-1BB) monoclonal antibody (Product # 13-1371-82) in Flow Cytometry
Tue Apr 16 00:00:00 UTC 2019
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.
Cancer cell
Arce Vargas F,Furness AJS,Litchfield K,Joshi K,Rosenthal R,Ghorani E,Solomon I,Lesko MH,Ruef N,Roddie C,Henry JY,Spain L,Ben Aissa A,Georgiou A,Wong YNS,Smith M,Strauss D,Hayes A,Nicol D,O'Brien T,Mårtensson L,Ljungars A,Teige I,Frendéus B,Pule M,Marafioti T,Gore M,Larkin J,Turajlic S,Swanton C,Peggs KS,Quezada SA
13-1371 was used in Flow cytometry/Cell sorting to examine the importance of Fc-gamma receptor binding in contributing to the activity of anti-CTLA4 antibodies.
Mon Apr 09 00:00:00 UTC 2018
Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells.
Cancer immunology research
Zahm CD,Colluru VT,McNeel DG
Published figure using CD137 (4-1BB) monoclonal antibody (Product # 13-1371-82) in Flow Cytometry
Tue Aug 01 00:00:00 UTC 2017
Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma.
Cancer immunology, immunotherapy : CII
Kroon P,Gadiot J,Peeters M,Gasparini A,Deken MA,Yagita H,Verheij M,Borst J,Blank CU,Verbrugge I
13-1371 was used in Flow cytometry/Cell sorting to examine the extent to which T cell co-stimulation and/or stereotactic body radiation therapy could enhance the therapeutic efficacy of T cell checkpoint blockade.
Wed Jun 01 00:00:00 UTC 2016
4-1BB ligand signaling to T cells limits T cell activation.
Journal of immunology (Baltimore, Md. : 1950)
Eun SY,Lee SW,Xu Y,Croft M
13-1371 was used in Flow cytometry/Cell sorting to show that 4-1BBL can transmit signals that limit T cell effector activity under tolerogenic conditions.
Thu Jan 01 00:00:00 UTC 2015
Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy.
Molecular therapy : the journal of the American Society of Gene Therapy
Devaud C,Westwood JA,John LB,Flynn JK,Paquet-Fifield S,Duong CP,Yong CS,Pegram HJ,Stacker SA,Achen MG,Stewart TJ,Snyder LA,Teng MW,Smyth MJ,Darcy PK,Kershaw MH
13-1371 was used in Flow cytometry/Cell sorting to explore the relationship between tumour microenvironments and efficacy of immunotherapy.
Wed Jan 01 00:00:00 UTC 2014
The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells.
Journal of immunology (Baltimore, Md. : 1950)
Zheng G,Wang B,Chen A
Sun Aug 15 00:00:00 UTC 2004